1 Herein,
we aimed to assess and compare the reproducibility and progno
2 We aimed to assess associations of hyperuricemia in patients
3 We aimed to assess feasibility, fidelity, and clinical outcom
4 We aimed to assess global implementation based on analysis of
5 We aimed to assess if >= 2-year survival has changed in relat
6 Therefore,
we aimed to assess,
in a real-life clinical setting, the abil
7 We aimed to assess its impact on the outcome of the SHIFT tri
8 We aimed to assess natural protection conferred by GAS agains
9 We aimed to assess non-communicable multimorbidity (co-occurr
10 We aimed to assess PrEP uptake and engagement after populatio
11 We aimed to assess safety and immunogenicity of the two novel
12 We aimed to assess the activity and safety of dabrafenib and
13 We aimed to assess the antitumour activity and safety of neoa
14 Here,
we aimed to assess the association between allergic inflammat
15 We aimed to assess the association between EGWG and daughters
16 Therefore,
we aimed to assess the association between recipient and dono
17 We aimed to assess the association between the clinical benef
18 We aimed to assess the associations between serum 25-hydroxyv
19 Therefore,
we aimed to assess the benefit of CT-based lung density measu
20 We aimed to assess the burden of chronic symptomatic FBDs on
21 We aimed to assess the capability of these factors to predict
22 ut its impact on respiratory command is unknown.Objectives:
We aimed to assess the effect of sleep deprivation on respira
23 We aimed to assess the effectiveness and safety of cystine as
24 Here,
we aimed to assess the effects of long-term doxycycline treat
25 We aimed to assess the efficacy and safety of abrocitinib mon
26 We aimed to assess the efficacy and safety of atezolizumab (a
27 We aimed to assess the efficacy and safety of mavacamten, a f
28 We aimed to assess the efficacy, safety, and immunogenicity o
29 We aimed to assess the impact of antiviral treatment on morta
30 We aimed to assess the national impact of COVID-19 on the pre
31 We aimed to assess the number of institutional births, their
32 We aimed to assess the performance of differing PCV schedules
33 We aimed to assess the response to single-agent selinexor, an
34 We aimed to assess the safety and activity of a non-surgical
35 We aimed to assess the safety of an infant formula with a mod
36 We aimed to assess the short-term and long-term risk of recur
37 ess cognitive flexibility during early infancy are lacking,
we aimed to assess the spatiotemporal developmental features
38 We aimed to assess the terminal phase pharmacokinetics and sa
39 We aimed to assess the validity of a self-reported questionna
40 We aimed to assess the validity of indicators of maternal and
41 We aimed to assess their incidence and to analyze their deter
42 We aimed to assess their long-term prognostic significance.
43 We aimed to assess this possible cross reactivity.
44 We aimed to assess whether adding biomarkers of kidney diseas
45 We aimed to assess whether denosumab combined with standard-o
46 We aimed to assess whether hemi pelvises are symmetrical in t
47 We aimed to assess whether LV strain will predict those who d
48 In this study
we aimed to assess whether public transport strikes were asso
49 We aimed to assess whether the population-level consumption o
50 We aimed to assess whether these indicators are associated wi